Intriguingly, high ACACA expression was inversely correlated with key immunomodulatory pathways, as evidenced by the suppression of interferon-α responses, the inflammatory signaling cascades, and complement activation, particularly in LGG, SARC, PAAD, and lung squamous cell carcinoma (LUSC). The gene discussed is ACACA; the disease is pancreatic adenocarcinoma.